Aurobindo Pharma reported INR15.86 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q4 Mar/2026 15.86 16.04 15.56 May/20
FY2026Q3 Dec/2025 15.67 15.33 14.56 Feb/09
FY2026Q2 Sep/2025 14.61 18.02 16.30 Nov/05
FY2026Q1 Jun/2025 14.20 17.41 15.76 Aug/03
FY2025Q4 Mar/2025 15.56 17.53 15.50 May/26




Eps Change Date
Cipla INR 6.86 8.34 Mar/2026
Divis Laboratories Ltd INR 28.29 6.31 Mar/2026
Dr.Reddys Laboratories INR 5.8 8.72 Mar/2026
Hindustan Unilever INR 12.5 3.47 Mar/2026
Sun Pharmaceuticals INR 9.5 3.3 Mar/2026
UPL INR 12.57 7.88 Mar/2026